Filtros de búsqueda

Lista de obras de Frederick L Locke

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

artículo científico publicado en 2018

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

artículo científico publicado en 2017

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

artículo científico publicado en 2017

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection

artículo científico publicado en 2016

Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma

artículo científico publicado en 2022

Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy-Related Toxicities

artículo científico publicado en 2019

Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results

artículo científico publicado en 2015

Outcomes of Patients with Large B-cell Lymphoma Progressing after Axicabtagene Ciloleucel

artículo científico publicado en 2020

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

artículo científico publicado en 2020

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

scientific article published on 13 May 2020

Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma

artículo científico publicado en 2015

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'.

artículo científico publicado en 2018

Tumor Microenvironment composition and severe cytokine release syndrome (CRS) Influence Toxicity in Patients with Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel

scientific article published on 15 July 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda